Newsroom
Sorted by: Latest
-
Infleqtion Convenes Business Leaders in London to Chart Quantum Commercial Value
OXFORD, England--(BUSINESS WIRE)--Infleqtion (NYSE: INFQ), a global leader in quantum computing and quantum sensing powered by neutral atom technology, will host the first Quantum Application Forum, an exclusive one-day event convening senior business and technology leaders on 3 November 2026 at IET Savoy Place in London. Executives responsible for technology, innovation and investment decisions will explore how quantum technology can address critical challenges, unlock commercial value and dri...
-
NUCLIDIUM and NorthStar Enter Long-term Strategic Partnership to Advance NUCLIDIUM’s Copper-67 Radiotheranostic Oncology Pipeline
BASEL, Switzerland & MUNICH & BELOIT, Wis.--(BUSINESS WIRE)--NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, LLC (NorthStar), a global radiopharmaceutical supply-chain partner, today announced a long-term strategic partnership through which NorthStar will produce Copper-67 (Cu-67) and provide comprehensive radiopharmaceutical manufacturing services to support NUCLIDIUM's therapeutic programs from clinical development through commercialization. Cop...
-
MedaSystems Launches MCP Server in Beta, Bringing Expanded Access Program Data to AI Assistants
MENLO PARK, Calif.--(BUSINESS WIRE)--MedaSystems, the SaaS platform for managing Expanded Access, Post-Trial Access and Investigator-Initiated Study programs, today announced the beta release of the MedaSystems MCP Server. Using the server, authorized users can ask plain-language questions about their program data from the AI assistants they already use, such as Microsoft Copilot, Claude and ChatGPT, without switching tools.The server is built on the Model Context Protocol (MCP), an open standar...
-
AITO se tourne vers l’Europe et entend y bâtir un écosystème automobile dynamique
PARIS--(BUSINESS WIRE)--À l’occasion du Mondial de l’Auto 2026 à Paris, Clifford Kang, membre du conseil d’administration et vice-président du groupe SERES, a annoncé qu’AITO prévoyait de faire officiellement son entrée sur le marché européen à l’automne 2027, marquant ainsi une nouvelle étape majeure de son développement international. Profondément attachée à l’héritage automobile européen, la marque entend collaborer avec des partenaires du monde entier et construire avec eux une croissance d...
-
AITO Looks Ahead to Europe, Building a Thriving Automotive Ecosystem
PARIS--(BUSINESS WIRE)--At the 2026 Paris Motor Show, Clifford Kang, Board Member and Vice President of SERES Group, announced that AITO plans to officially enter the European market in autumn 2027, marking another major step in its global development. With deep respect for Europe’s automotive heritage, AITO looks forward to collaborating and growing with partners around the world. https://www.youtube.com/watch?app=desktop&v=6Zoz_hxLRxk In China, AITO has earned the trust of over 1.2 millio...
-
Horizon3 Expands in Singapore to Accelerate AI‑Native Proactive Security Across Southeast Asia
SINGAPORE--(BUSINESS WIRE)--Horizon3, the AI-native proactive security leader, today announced a strategic expansion in Singapore, supported by new investments from EDBI and its parent SG Growth Capital, the strategic investment platform established by the Singapore Economic Development Board and Enterprise Singapore to support companies from early to growth stages. This expansion is to meet accelerating demand across Southeast Asia for continuous, evidence‑based security validation as AI‑drive...
-
Flashlight Capital: Owner Family Is Sucking Choco Pie Maker Orion Dry
SINGAPORE--(BUSINESS WIRE)--Flashlight Capital Partners Pte. Ltd. (“Flashlight Capital”), a shareholder of Orion Corp. (KRX: 271560), the maker of Choco Pie, today sent an open letter to Orion’s board with five requests, seeking a response by November 13, 2026. Orion is Korea’s largest confectioner, with a 22% domestic share and two-thirds of sales abroad. Yet its share price has been flat since its 2017 spin-off, and it trades at 3.0x EV/EBITDA, a quarter of the global peer median (11.5x). Fla...
-
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight as the Agentic Foundation for Its Up to $1 Billion Tokenized Solar and AI Computing Program with Meridian and Up to $130 Million IP-Backed Transaction with BeyondAI
LAKE MARY, Fla.--(BUSINESS WIRE)--OpenWorld, Inc. (“OpenWorld” or the “Company”) (NASDAQ: OPNW), an innovation company advancing global real-world asset (“RWA”) tokenization, today announced the signing of a definitive merger agreement to acquire Blocksight and outlined how its acquisition of Blocksight Holdings Co. (“Blocksight”), announced on October 1, 2026, is intended to serve as the operating foundation for the Company’s tokenized financing programs in infrastructure and energy. Blocksigh...
-
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business update from YT Jia, Founder and Global CEO of FF. “Welcome to Weekly Report 77. This week, let’s start with some big news from FFR. On October 26, we will hold FFR’s listing ceremony and first Investor Day at the Nasdaq Tower in New York. Our management team will share more a...
-
ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts featuring its technology will be presented at the 2026 European Society for Medical Oncology (ESMO) Annual Congress, taking place October 23–26 in Madrid, Spain.New evidence highlights the power of Natera’s latest ultrasensitive molecular residual disease (MRD) technology, Signatera Genome with Phased and Structural Variants, which has demonstrat...